Incannex Healthcare Inc

For the period ended Sep 30, 2024. Filed Nov 14, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 14, 2024

IXHL$2.01-8.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Balance Sheets

	September 30, 2024	June 30, 2024
Assets
Current assets:
Cash and cash equivalents	$3,627	$5,858
Prepaid expenses and other assets	489	507
Research and Development (“R&D”) tax incentive receivable	11,093	9,837
Total current assets	15,209	16,202
Property, plant and equipment, net	428	472
Operating lease right-of-use assets	411	373
Total assets	$16,048	$17,047
Liabilities and stockholders’ equity
Current liabilities:
Trade and other payables	$1,555	$612
Accrued expenses and other current liabilities	7,487	4,845
Operating lease liabilities, current	190	163
Total current liabilities	9,232	5,620
Operating lease liabilities, non-current	221	210
Total liabilities	9,453	5,830
Commitments and contingencies (Note 8)
Stockholders’ equity:
Common Stock, $0.0001 par value per share – 100,000,000 shares authorized; 17,642,832 and 17,642,832 shares issued and outstanding at September 30, 2024 and June 30, 2024, respectively	2	2
Preferred Stock, $0.0001 par value per share, 10,000,000 shares authorized; no shares issued or outstanding at September 30, 2024 and June 30, 2024, respectively	—	—
Additional paid-in capital	125,677	125,218
Accumulated deficit	(116,091)	(110,671)
Foreign currency translation reserve	(2,993)	(3,332)
Total stockholders’ equity	6,595	11,217
Total liabilities and stockholders’ equity	$16,048	$17,047

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.